Linked Life Data

18514131

Source:http://linkedlifedata.com/resource/pubmed/id/18514131

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2008-6-2
pubmed:abstractText
The prognosis of thymic epithelial tumors depends on their separation into thymoma and thymic carcinoma, as well as the extent to which they involve adjacent tissues and organs. To formalize evaluations of the latter attribute, several staging systems have been developed over the past 30 years. These include the Masaoka, Bergh, Wilkins-Castleman, Groupe d'Etudes des Tumeurs Thymiques, and tumor-nodal-metastasis schemes. The first of those formulations is most commonly employed in clinical practice, at least in the United States. The author believes that surgical-pathologic staging is the most powerful and reliable prognosticator for thymoma, as compared with histologic subtype-related prediction of behavior for that tumor type. Those topics, as well as affiliated issues concerning tissue sampling and staging techniques, are discussed in this article.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0889-8588
pubmed:author
pubmed:issnType
Print
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
527-42
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Prognostic factors for thymic epithelial neoplasms, with emphasis on tumor staging.
pubmed:affiliation
Division of Surgical Pathology and Cytopathology, University of Virginia Medical Center, University of Virginia Health System, Charlottesville, VA 22908-0214, USA. mrw9c@virginia.edu
pubmed:publicationType
Journal Article, Review